Related references
Note: Only part of the references are listed.Implication of decreased serum complement 3 in patients with diabetic nephropathy
Junlin Zhang et al.
ACTA DIABETOLOGICA (2018)
Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship
Yan Borne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
A review of human diseases caused or exacerbated by aberrant complement activation
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2017)
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmo Diet and Cancer Study
Christina-Alexandra Schulz et al.
KIDNEY INTERNATIONAL REPORTS (2017)
The Expression Profile of Complement Components in Podocytes
Xuejuan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Complement in Kidney Disease: Core Curriculum 2015
Joshua M. Thurman
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression
Maria Kohl et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2015)
Are Obesity-Related Insulin Resistance and Type 2 Diabetes Autoimmune Diseases?
Sue Tsai et al.
DIABETES (2015)
Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease
Kentaro Kohagura et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study
Nick Wlazlo et al.
DIABETES CARE (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
C3 glomerulopathy: consensus report
Matthew C. Pickering et al.
KIDNEY INTERNATIONAL (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010
Abdul Rashid Qureshi et al.
CLINICAL KIDNEY JOURNAL (2013)
Serum Complement C3 Predicts Renal Arteriolosclerosis in Non-Diabetic Chronic Kidney Disease
Chiari Kojima et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson et al.
BMC PUBLIC HEALTH (2011)
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study
Anoop Shankar et al.
KIDNEY INTERNATIONAL (2011)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog et al.
KIDNEY INTERNATIONAL (2011)
Complement and its role in innate and adaptive immune responses
Jason R. Dunkelberger et al.
CELL RESEARCH (2010)
Renal Medicine 2 Early recognition and prevention of chronic kidney disease
Matthew T. James et al.
LANCET (2010)
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
Emanuele Di Angelantonio et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate - Comparison study in an elderly population
Antonio Muscari et al.
DIABETES CARE (2007)
Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study
G. Engstrom et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Complement C3 and C-reactive protein levels in patients with stable coronary artery disease
R Ajjan et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
High expression of complement components in omental adipose tissue in obese men
BG Gabrielsson et al.
OBESITY RESEARCH (2003)
Intrarenal synthesis of complement
WD Zhou et al.
KIDNEY INTERNATIONAL (2001)
Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
A Sahu et al.
IMMUNOLOGICAL REVIEWS (2001)
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study
P Muntner et al.
KIDNEY INTERNATIONAL (2000)
Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden
B Hedblad et al.
DIABETIC MEDICINE (2000)
Share Paper
